Lipodystrophy
Fat Loss / Fat Accumulation / Wasting / Cosmetic Procedures / Growth Hormone / Buffalo Hump

Strength Training Improves Insulin Sensitivity and Reduces Body Fat in HIV Positive Patients with Lipodystrophy - 10/17/08

Long-term Safety and Effectiveness of Growth Hormone Releasing Factor Tesamorelin for Lipodystrophy - 9/15/08

Genetic Factors May Influence Fat Loss and Accumulation in People with HIV - 9/15/08

Switching from Other Ritonavir-boosted Protease Inhibitors to Boosted Atazanavir (Reyataz) Did Not Improve Body Fat Accumulation: REAL Study - 8/19/2008

Growth Hormone Improves Lipodystrophy, but Has Detrimental Effect on Blood Glucose - 8/08/08

Abdominal Fat Accumulation, Elevated ALT, and Liver Steatosis in HIV Positive Individuals - 6/24/08

Phase 3 Study Shows Growth Hormone Releasing Factor Tesamorelin Reduces Excess Visceral Fat in HIV patients - 6/20/08

Long-term Fat Loss among Treatment-naive Patients Starting Combination Therapy Containing Stavudine (Zerit), Zidovudine (Retrovir), or Abacavir (Ziagen) - 5/30/08

Body Fat and Blood Lipid Levels in Men and Women with HIV - 5/16/08

Genetic Variation Predicts Higher Risk of Lipoatrophy in Patients on HAART - 5/02/08

Theratechnologies Announces Promising 52-week Study Data on Tesamorelin (TH9507) for Treatment of Lipodystrophy in HIV Patients - 10/05/07

Compared to Efavirenz, Lopinavir/Ritonavir Has Less Lipoatrophy When Given with NRTI - 3/09/07

Switching to Lopinavir/Ritonavir (Kaletra) plus Efavirenz (Sustiva) Increases Limb Fat, but also Raises Serum Lipid Levels - 3/09/07

"Buffalo Hump" Linked to Use of d4T - 2/16/07

FDA Approves Radiesse for Facial Lipoatrophy - 1/05/07

Poly-L-lactic Acid Helps in HAART-related Facial Wasting - 3/02/05

Growth Hormone-releasing Hormone Could Help Build Bone in HIV Patients - 5/23/05